Viewed0
Downloads 281
HTML Click0
A review of research progress in infection and esophageal cancer
Esophageal Cancer Issue: 2025 02期 Page: 1-7 Publish Date: 2023/05/16
| Title: | Title: A review of research progress in infection and esophageal cancer | ||
|---|---|---|---|
| Author(s): |
Author(s): Jingjing Guan1, Ke Liu1'2'3, Shegan Gao3* 1. The First Affiliated Hospital of Henan University of Science and Technology, Information department, Luoyang, 471003, China 2. School of Information Engineering, Henan University of Sci ence and Technology, Luoyang, 471003, China 3. Henan Key Laboratory of Cancer Epigenetics, Cancer Hospi tal, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technolo gy, Luoyang, 471003, China |
||
| Keywords: |
Keywords: Infection, Esophageal cancer, Bacterial infections |
||
| CLC: |
CLC: |
||
| DOI: |
DOI: |
||
| Abstract: |
Abstract: Apart from geneti('and epigenetic pre-disposition, many envi ronmental risk factors for esophageal cancer have been identi fied, such as smoking, drinking, eating over-hot or pickled food, et al. which lead to various irritants and subsequent esophageal ('ancer lesions. The latest research shows the essential role of in fectious agents such as bacteria and viruses in the development of a variety of cancers. However, the specific pathogen that plays a significant role in the occurrence and evolution of esophageal ('ancer remains unclear. This review therefore summarizes and discusses the research progress of the pro- tumorigeni (' infe(' 一tious agents and their interactions with esophageal cancer. |
||
| References: |
References: [1] Jemal A, Bray F, Center M, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. [2] Pennathur A, Gibson MK, Jobe BA, et al. Oesoph ageal carcinoma. Lancet 2013; 381: 400-12. [3] Pennathur A, Luketich JD. Resection for esopha geal cancer: strategies for optimal management. Ann Thorac Surg 2008; 85: S751-6. [4] Chen W, Zheng R, Baade PD, et al. Cancer statis tics in China.CA Cancer J Clin 2015; 66: 115-32. [5] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of can cer. GLOBOCAN2008; 127: 2893-917. [6] Ando, Nobutoshi. Esophageal squamous cell car cinoma. Springer 2015; 12-24. [7] Qi YJ, Chao WX, Chiu JF. An overview of esopha geal squamous cell carcinoma proteomic. Pro teomics 2012; 75: 3129-37. [8] Nik-Zainal S, Alexandrov LB, Wedge DC, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149: 979-93. [9] Guichard C, Amaddeo G, lmbeaud S, et al. lnte grated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-8. [10] Mankoo P. Integrated genomic analyses of ovari an carcinoma. Nature 2011; 474: 609-15. [11] Mann M, Kulak NA, Nagaraj N, et al. The com-ing age of complete, accurate, and ubiquitous proteomes. Mol Cell 2013; 49: 583-90. [12] Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature 2009; 461: 218-23. [13] Coussens LM, Werb Z. Inflammation and can cer. Nature 2002; 420: 860-7. [14] Merrell DS, Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature 2004; 430:250-6. [15] Wang S, Huang XX, Yu PF, et al. Study on the relationship between intestinal microflora dys regulation and the occurrence and development of colon cancer. Chinese Pharmacological Bulle ti 2014; 30:1045-9. [16] Feng CY, Guo XK. Research progress of bacte ria as anti-tumor vector. Chinese Journal of Mi croecology 2006; 18:414-5. [17] Bettegowda C, Huang X, Lin J, et al. The ge nome and transcriptomes of the anti-tumor agent Clostridium novy-NT. Nat Biotechnol 2006; 24:1573-80. [18] Barbe S, Van Mellaert L, Theys J, et al. Secreto ry production of biologically active rat interleu kin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment. FEMS Micro biol Lett 2005; 246: 67-73. [19] Sokol H, Pigneur B, Watterlot L, et al. Faecali bacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbi ota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-6. [20] Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation im prove symptoms of irritable bowel syndrome. Dig Dis Sci 2005; 50: 758-66. [21] Huycke MM, Gaskins HR. Commensal bacte ria, redox stress, and colorectal cancer: mecha nisms and mod els. Exp Biol Med 2004; 229: 586-97. [22] Brady LJ, Gallaher DD, Busta FF. The role of probiotic cultures in the prevention of colon can- cer. Nutrition 2000; 130:410S-4S. [23] Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070- 5. [24] Scott FW. Food-induced type 1 diabetes in the BB rat. Diabetes Metab Res 1996; 12: 341-59. [25] Vrieze A, Holleman F, Zoetendal EG, et al. The environment within: how gut microbiota may in fluence metabolism and body composition. Dia betologia 2010; 53: 606-13. [26] Lazcano Ponce E.C, Miquel JF, et al. Epidemiol ogy and molecular pathology of gall-bladder cancer. CA Cancer J Clin 2001; 51: 349-64. [27] Yang L, Francois F, Pei Z. Molecular pathways: pathogenesis and clinical implications of micro biome alteration in esophagitis and Barrett esophagus. Clin Cancer Res 2012; 18: 2138-44. [28] Yang L, Wang SK, Sun GJ, et al. Risk factors for esophageal cancer: a case-control study. APJCP 2009; 29: 249-52. [29] Pei Z, Yang L, Peek RM, et al. Bacterial biota in reflux esophagitis and Barrett's esophagus. World J Gastroenterol 2005; 11: 7277-83. [30] Yu DH, Cheng ZN, Jia JH, et al. Relation be tween Helicobacter pylori L-form infection and tumor angiogenesis in human esophageal carci noma. Chinese Journal of Oncology 2003; 25: 51-4. [31] Li WS, Tian DP, Guan XY, et al. Esophageal in traepithelial invasion of Helicobacter pylori corre lates with atypical hyperplasia. Int. ]. Cancer 2014; 134: 2626-32. [32] Nasrollahzadeh D, Malekzadeh R, Ploner A, et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. SCI Rep UK 2015; 5: 8820. [33] Tateda M, Shiga K, Saijo S, et al. Streptococcus anginosus in head and neck squamous cell carci noma: implication in carcinogenesis. Int J Mol Med 2000; 6: 699-703. [34] Atanasova KR, Atanasova 0. Looking in the Por-phyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbial 2014; 29: 55-66. [35] Whitmore SE, Lamont RJ. Oral bacteria and can cer. PLoS Pathog 2014; 10e1003933. [36] Inaba H, Sugita H, Kuboniwa M, et al. Porphy romonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbial 2014; 16: 131-45. [37] Gao SG, Li SG, Ma ZK, et al. Presence of Por phyromonas gingivalis in esophagus and its asso ciation with the clinicopathological characteris tics and survival in patients with esophageal cancer. Infect Agent Cancer 2016; 11:3. [38] Li SG, Jia RN, Gao SG. Relationship between Porphyromonas gingivalis and clinicopathologi cal features and prognosis of esophageal cancer. Chongqing Medical Journal 2018; 47: 3614-7. [39] Gao SG, Liu RM, Zhao YG, et al. Integrative to pological analysis of mass spectrometry data re veals molecular features with clinical relevance in esophageal squamous cell carcinoma. Sci Rep-UK 2016; 6: 215-86. [40] Gao SG, Yang JQ, Ma ZK, et al. Preoperative se rum immunoglobulin G and A antibodies to Por phyromonas gingivalis are potential serum bio markers for the diagnosis and prognosis of esoph ageal squamous cell carcinoma. BMC Cancer 2018;18: 17. [41] Syrjanen KJ, Pyrhonen S. Demonstration of hu man papilloma virus antigen in the condyloma- tous lesions of the uterine cervix by immunoper oxidase technique. Gynecol Obstet Invest 1982; 14: 90-6. [42] Yahyapour Y, Shamsi-Shahrabadi M, Mah moudi M, et al. High - risk and low - risk hu man papillomavirus in esophageal squamous cell carcinoma at Mazanda-ran, Northern Iran. Pathol Oncol Res 2013; 19: 385-91. [43] Agalliu I, Chen Z, Wang T, et al. Oral alpha, be ta and gamma HPV types and risk of incident esophageal cancer. Cancer Epidemiol Biomark ers Prev 2018. [44] Kunzmann AT, Graham S, McShane CM, et al. The prevalence of viral agents in esophageal ad enocarcinoma and Barrett's esophagus: a sys tematic review Eur. Gastroenterology and Hepa tol 2017; 29: 817-25. [45] Del Valle L, White MK, Enam S, et al. Detection of JC virus DNA sequences and expression of vi ral T antigen and agnoprotein in esophageal car cinoma.Cancer 2005; 103: 516-27. [46] Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by in ducing atrophic gastritis. Gastroenterol 1999; 94: 3468-72. [47] Tomasello, Giordano GF, Mazzola M, et al. Heli cobacter pylori and Barrett's esophagus: a pro tective factor or a real cause. Biol Regul Ho meost 2017; Agents 31: 9-15. Tripath M, Swanson PE. Rare tumors of esopha geal squamous mucosa. Ann NY Acad Sci 2016; 1381: 122-32.
|
||
| Memo: |
Memo: |
